🔗 Share this article

Texas Attorney General Paxton is filing a lawsuit against the manufacturers of Tylenol, alleging the firms hid potential risks that the medication presented to pediatric neurological development.

The court filing follows thirty days after Donald Trump promoted an unproven link between consuming Tylenol - referred to as acetaminophen - during pregnancy and autism spectrum disorder in children.

Paxton is filing suit against J&J, which once produced the medication, the only pain reliever recommended for pregnant women, and the current manufacturer, which now manufacturers it.

In a declaration, he stated they "deceived the public by gaining financially from discomfort and pushing pills without regard for the potential hazards."

Kenvue asserts there is lacking scientific proof tying Tylenol to autism.

"These corporations misled for generations, deliberately risking numerous people to line their pockets," Paxton, a Republican, declared.

The company commented that it was "deeply concerned by the spread of false claims on the reliability of acetaminophen and the possible consequences that could have on the well-being of US mothers and children."

On its official site, Kenvue also said it had "continuously evaluated the applicable studies and there is no credible data that demonstrates a established connection between taking acetaminophen and autism spectrum disorder."

Groups acting on behalf of doctors and health professionals concur.

ACOG has stated acetaminophen - the main ingredient in acetaminophen - is a restricted selection for pregnant women to manage discomfort and elevated temperature, which can create major wellness concerns if left untreated.

"In multiple decades of studies on the utilization of acetaminophen in pregnancy, not a single reputable study has definitively established that the usage of acetaminophen in any period of gestation results in neurodevelopmental disorders in children," the association commented.

This legal action mentions latest statements from the former administration in claiming the drug is potentially dangerous.

Recently, the former president generated worry from public health officials when he instructed pregnant women to "struggle intensely" not to use Tylenol when unwell.

The FDA then issued a notice that physicians should contemplate reducing the use of Tylenol, while also stating that "a causal relationship" between the drug and autism spectrum disorder in minors has not been established.

Health Secretary Robert F Kennedy Jr, who oversees the FDA, had pledged in spring to undertake "a massive testing and research effort" that would determine the cause of autism in a matter of months.

But experts advised that finding a single cause of autism - considered by experts to be the outcome of a intricate combination of genetic and external influences - would prove challenging.

Autism spectrum disorder is a type of lifelong neurodivergence and disability that influences how persons perceive and interact with the surroundings, and is diagnosed using medical professional evaluations.

In his lawsuit, Paxton - a Trump ally who is seeking federal office - alleges the manufacturer and J&J "deliberately disregarded and tried to quiet the evidence" around acetaminophen and autism.

This legal action attempts to require the firms "eliminate any commercial messaging" that asserts acetaminophen is reliable for women during pregnancy.

This legal action parallels the concerns of a collection of guardians of minors with autism spectrum disorder and attention deficit hyperactivity disorder who filed suit against the manufacturers of acetaminophen in recently.

The court dismissed the lawsuit, declaring investigations from the plaintiffs' authorities was not conclusive.